Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of New Formulation BIIB061 in Healthy Volunteers
NCT02521545Phase 1Completed
- Sponsor
- Biogen
- Start
- Jul 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BIIB061 in multiple sclerosis (MS), sponsored by Biogen. Primary endpoints: Area under the concentration-time curve from time 0 to infinity at Day 21, Area under the concentration-time curve from time 0 to time of the last measurable concentration at Day 21 and 1 more. Started Jul 2015; status: completed.
02
Drugs
BIIB061
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02521545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02521545.